Table 4.
Five-year mortality |
||
---|---|---|
Unadjusted OR (95% CI) | †Adjusted OR (95% CI) | |
Symptom cluster | ||
Subgroup 1 | 1 | 1 |
Subgroup 2 | 1·51* (1·01–2·27) | 1·27 (0.82–1·99) |
Subgroup 3 | 1·92* (1·29–2·86) | 1·75* (1·12–2·74) |
Dyspnoea‡ | ||
≤51 | 1 | |
52–65 | 1·35 (0.90–2·03) | |
≥66 | 1·87* (1·26–2·79) | |
Anxiety‡ | ||
≤26 | 1 | |
27–36 | 1·08 (0.71–1·63) | |
≥37 | 1·33 (0.88–2·01) | |
Depression‡ | ||
≤5 | 1 | |
6–9 | 1·40 (0.91–2·13) | |
≥10 | 1·90* (1·28–2·84) | |
Fatigue‡ | ||
≥51 | 1 | |
31–50 | 1·01 (0.69–1·48) | |
≤30 | 1·29 (0.86–1·95) |
p<0.05.
Covariates include age, gender, race, education level, income level, marital status, pack years of smoking, FEV1% predicted, PaCO2, physical component scale in MOS-36 and number of healthcare use.
Scores were from University of California, San Diego, Shortness of Breath Questionnaire, Spielberger State-Trait Anxiety Inventory, Beck Depression Inventory and vitality subscale in Medical Outcomes Study 36-Item Short-Form Health Survey.
For this analysis, we used cutpoints that divided the sample into three equal groups for each of the single symptoms.
All analyses were performed separately.